Pharmaceutical Executive-12-01-2010

Pharmaceutical Executive

Taiwan: Pharma at the Tipping Point

December 01, 2010

0

0

After many years of building up an impressive resource base, the industry is finally ready to take advantage of the wave of enthusiasm and interest surounding pharma and biotech that is sweeping the nation

Taiwan: Pharma at the Tipping Point

December 01, 2010

0

0

After many years of building up an impressive resource base, the industry is finally ready to take advantage of the wave of enthusiasm and interest surounding pharma and biotech that is sweeping the nation

Don't Judge a Book by its Cover (Or Its Title)

December 01, 2010

0

0

With a fiercely competitive spirit and grand ambitions that reach far beyond Taiwan, Standard is showing that it is far from the middle-of-the-road company its name implies

Gentle Collisions in Marketing

December 01, 2010

Columns

0

0

Healthcare marketing in today's post-recession economy is not about one-size-fits-all vehicles, but rather about bringing your prouct into consumers' lives in a series of personal, non-invasive ways

Emerging Stakeholders with Clout: The Press Power Behind ProPublica

December 01, 2010

Columns

0

0

The new investigative journalism organization recently took an in-depth look at pharma with its "Dollars for Docs" report. In return, Pharm Exec takes a look back at ProPublica

The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator

December 01, 2010

Features

0

0

Outgoing EMA Director Thomas Lonngren discusses a decade at the helm of Europe's top regulatory office

Is Euroland Following the US Disclosure Lead?

December 01, 2010

Columns

0

0

Cegedim survey documents whether European industry is ready for the challenge of new compliance and disclosure risks on promotional spend

Nicotine Addiction: What Lights Up the Field

December 01, 2010

Features

0

0

Pharm Exec's Pipeline Report 2018